INmune Bio Inc’s recent filing unveils that its Chief Financial Officer Moss David J acquired Company’s shares for reported $52868.0 on Sep 30 ’24. In the deal valued at $5.29 per share,10,000 shares were bought. As a result of this transaction, Moss David J now holds 1,285,869 shares worth roughly $7.92 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Tesi Raymond Joseph bought 15,380 shares, generating $98,048 in total proceeds. Upon buying the shares at $6.38, the President and CEO now owns 1,554,106 shares.
Before that, Moss David J bought 7,690 shares. INmune Bio Inc shares valued at $49,024 were divested by the Chief Financial Officer at a price of $6.38 per share. As a result of the transaction, Moss David J now holds 1,275,869 shares, worth roughly $7.86 million.
Alliance Global Partners initiated its INmune Bio Inc [INMB] rating to a Buy in a research note published on October 21, 2024; the price target was $20. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in late September with a ‘”an Outperform”‘ rating. Scotiabank began covering INMB with “Sector outperform” recommendation on August 22, 2024. Robert W. Baird started covering the stock on June 01, 2023. It rated INMB as “an Outperform”.
Price Performance Review of INMB
On Monday, INmune Bio Inc [NASDAQ:INMB] saw its stock jump 13.75% to $6.16. Over the last five days, the stock has gained 19.02%. INmune Bio Inc shares have fallen nearly -45.25% since the year began. Nevertheless, the stocks have fallen -11.68% over the past one year. While a 52-week high of $14.74 was reached on 02/14/24, a 52-week low of $4.78 was recorded on 10/15/24. SMA at 50 days reached $5.70, while 200 days put it at $9.10.
Levels Of Support And Resistance For INMB Stock
The 24-hour chart illustrates a support level at 5.70, which if violated will result in even more drops to 5.24. On the upside, there is a resistance level at 6.58. A further resistance level may holdings at 7.00. The Relative Strength Index (RSI) on the 14-day chart is 64.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.86%. Stochastics %K at 71.17% indicates the stock is a holding.
How much short interest is there in INmune Bio Inc?
A steep rise in short interest was recorded in INmune Bio Inc stocks on 2024-10-15, dropping by -0.32 million shares to a total of 2.83 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 3.16 million shares. There was a decline of -11.48%, which implies that there is a negative sentiment for the stock.
